Sponsored Content
Steatosis Liver Disease Shows Increased Risk of Diabetes for Patients With Atrial Fibrillation
Investigators find that the risk for new-onset diabetes is especially prominent for patients aged 20 to 29 years.
Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications
In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.
Risk of Adverse Pregnancy Outcomes Increases With Hepatitis B, Gestational Diabetes
Hepatitis B and liver functions have been found to be independent risk factors for gestational diabetes and are found to have the highest prevalence of abnormalities.
The Pharmacist’s Role in Counseling Patients on GLP-1 Medications
With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.
Addressing Underdiagnosed Diabetes Prevents Complications, Increased Mortality Rates
A significant number of patients remain unaware of their diabetes, signaling a need for better diagnostic efforts.
Diabetes Microvascular Complications Linked With Cognitive Impairment, Depression
The associations and strengths of these links varied by the complication type, including diabetic nephropathy, neuropathy, and retinopathy.
